(MRU) Metro - Ratings and Ratios
Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA59162N1096
MRU: Food, Pharmaceuticals, Grocery, Bakery, Dairy, Meats, Produce
Metro Inc. is one of Canadas leading grocery and pharmaceutical retailers, operating a vast network of stores across the country. Founded in 1947 and headquartered in Montreal, the company has built a strong presence in the food and drug retail sectors, serving millions of Canadian households. Metro operates under multiple banners, including Metro, Super C, Food Basics, and Jean Coutu, among others, catering to a wide range of consumer preferences and budgets. This diversified approach allows the company to maintain its market share in a highly competitive retail landscape.
As a vertically integrated business, Metro not only retails food and pharmaceutical products but also manufactures and distributes them. The company produces private-label products under brands like Irresistibles, Selection, and Personnelle, which contribute significantly to its margins. Additionally, Metro offers online grocery shopping services, a critical component of its strategy to adapt to the evolving e-commerce landscape. Its ability to control parts of its supply chain enhances operational efficiency and profitability.
Metros financial health is supported by its stable cash flows, driven by the essential nature of its products. The companys market capitalization of over $20 billion CAD reflects its scale and dominance in the Canadian retail sector. With a P/E ratio of 21.16 and a forward P/E of 19.34, Metro is valued at a premium, indicating investor confidence in its growth prospects. The P/S ratio of 0.94 suggests that the company is efficiently generating revenue relative to its market value.
For investors, Metros appeal lies in its defensive characteristics, as grocery and pharmaceutical sales remain resilient during economic downturns. The companys focus on private-label products and its diversified store formats further strengthen its competitive position. With a long history of operations and a strong brand portfolio, Metro Inc. is a key player in Canadas retail industry, offering a combination of stability and growth potential for long-term investors.
Additional Sources for MRU Stock
MRU Stock Overview
Market Cap in USD | 14,749m |
Sector | Consumer Defensive |
Industry | Grocery Stores |
GiC Sub-Industry | Food Retail |
IPO / Inception |
MRU Stock Ratings
Growth 5y | 86.4% |
Fundamental | 36.6% |
Dividend | 63.8% |
Rel. Strength Industry | 16.9 |
Analysts | - |
Fair Price Momentum | 103.90 CAD |
Fair Price DCF | 110.65 CAD |
MRU Dividends
Dividend Yield 12m | 1.56% |
Yield on Cost 5y | 3.00% |
Annual Growth 5y | 8.13% |
Payout Consistency | 100.0% |
MRU Growth Ratios
Growth Correlation 3m | 47.6% |
Growth Correlation 12m | 95.7% |
Growth Correlation 5y | 92.4% |
CAGR 5y | 15.69% |
CAGR/Max DD 5y | 0.82 |
Sharpe Ratio 12m | 1.32 |
Alpha | 24.80 |
Beta | 0.37 |
Volatility | 14.89% |
Current Volume | 531.8k |
Average Volume 20d | 587.3k |
As of March 11, 2025, the stock is trading at CAD 95.80 with a total of 531,764 shares traded.
Over the past week, the price has changed by +0.16%, over one month by +4.51%, over three months by +3.26% and over the past year by +31.49%.
Partly, yes. Based on ValueRay Fundamental Analyses, Metro (TO:MRU) is currently (March 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 36.56 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MRU as of March 2025 is 103.90. This means that MRU is currently overvalued and has a potential downside of 8.46%.
Metro has no consensus analysts rating.
According to ValueRays Forecast Model, MRU Metro will be worth about 114.1 in March 2026. The stock is currently trading at 95.80. This means that the stock has a potential upside of +19.1%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 93.2 | -2.7% |
Analysts Target Price | - | - |
ValueRay Target Price | 114.1 | 19.1% |